Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysis. (Q53214902)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17147006%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17147006%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

alpha-1-antitrypsin deficiency

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17147006%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Kenneth M Shermock

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17147006%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Thomas R Gildea

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17147006%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

James K Stoller

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17147006%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

language of work or name

English

0 references

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17147006%20AND%20SRC:MED&resulttype=core&format=json

COPD: Journal of Chronic Obstructive Pulmonary Disease

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17147006%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17147006%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17147006%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

411-418

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17147006%20AND%20SRC:MED&resulttype=core&format=json

Population screening in the age of genomic medicine

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Four-year-old children with alpha 1-antitrypsin deficiency. Clinical follow-up and parental attitudes towards neonatal screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Ethical, legal, and social implications of genomic medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Neonatal screening for alpha1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Alpha 1-antitrypsin screening of 18-year-old men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Young adults with alpha 1-antitrypsin deficiency identified neonatally: their health, knowledge about and adaptation to the high-risk condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Psychological consequences of neonatal screening for alpha 1-antitrypsin deficiency. Parental reactions to the first news of their infants' deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Augmentation therapy for severe alpha 1-antitrypsin deficiency: is the jury still out on a trial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Pharmacoeconomic evaluation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

A model for analyzing the cost of the main clinical events after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Multi-attribute health status classification systems. Health Utilities Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Neonatal alpha1-antitrypsin screening: parents' views and reactions 20 years after the identification of the deficiency state

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469

Identifying children at high somatic risk: long-term effects on mother-child interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550500346469